Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Transfusion|March 10, 2001
PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trialO Rick, N Schwella, J Beyer, et al.Vox Sanguinis|January 1, 1994
Microbiologic contamination of peripheral blood stem cell autograftsN Schwella, R Zimmermann, H G Heuft, et al.British Journal of Cancer|July 3, 2003
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trialC Bokemeyer, N Schleucher, B Metzner, et al.Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.British Journal of Cancer|September 17, 2002
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H Klaproth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, S Weinknecht, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, J Beyer, R Liersch, et al.Die Rehabilitation|January 12, 2008
[Lymphedema in patients with breast cancer--a consensus regarding diagnostics and therapy in patients with postoperative lymphedema after primary breast cancer]U Seifart, U-S Albert, M-E Heim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H-G Derigs, et al.European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell supportC Kollmannsberger, N Schleucher, O Rick, et al.Pageof 5